Wiegand U K, Bode F, Schneider R, Taubert G, Brandes A, Peters W, Katus H A, Potratz J
Medical University of Luebeck, Department of Internal Medicine II, Germany.
J Cardiovasc Electrophysiol. 1999 Apr;10(4):513-20. doi: 10.1111/j.1540-8167.1999.tb00707.x.
Single lead VDD pacing has offered an alternative to DDD systems in patients with isolated AV block. Up to now, however, the relative performance of these pacemaker systems was not systematically compared.
Three hundred sixty patients who received either a VDD pacemaker (n = 180) or a DDD device (n = 180) with a bipolar atrial lead were investigated prospectively for a mean period of 30 +/- 13 months. Pacemaker function was analyzed by telemetry, Holter monitoring, and exercise ECG. Time of implantation and fluoroscopy was significantly lower with VDD devices (44.3 +/- 5.1 min vs 74.4 +/- 13.5 min and 4.6 +/- 2.5 min vs 10.3 +/- 5.6 min in DDD pacemakers, respectively). Intermittent atrial undersensing occurred in 23.3% of patients with a VDD pacemaker and in 9.4% with DDD devices (NS). The incidence of atrial tachyarrhythmias did not differ between the VDD (6.7%) and the DDD group (6.1%). Sinus node dysfunction developed in 1.9% of patients, but the vast majority (85.7%) of patients were asymptomatic. There was a tendency for a higher rate of operative revisions in the DDD group (6.1% vs 3.3% in VDD pacemakers, P = 0.15). Cumulative maintenance of AV-synchronized pacing mode was 94.9% in patients with VDD pacemakers and 92.1% with DDD devices (NS).
With the benefit of a simpler implant procedure, long-term outcome of single lead VDD pacing is equivalent to DDD pacing in patients with AV block and preoperative normal sinus node function.
对于孤立性房室传导阻滞患者,单导联VDD起搏为DDD系统提供了一种替代方案。然而,迄今为止,尚未对这些起搏器系统的相对性能进行系统比较。
前瞻性研究了360例接受VDD起搏器(n = 180)或带双极心房导线的DDD装置(n = 180)的患者,平均随访时间为30±13个月。通过遥测、动态心电图监测和运动心电图分析起搏器功能。VDD装置的植入时间和透视时间明显更短(VDD起搏器分别为44.3±5.1分钟和4.6±2.5分钟,DDD起搏器分别为74.4±13.5分钟和10.3±5.6分钟)。23.3%的VDD起搏器患者和9.4%的DDD装置患者出现间歇性心房感知不足(无统计学差异)。VDD组(6.7%)和DDD组(6.1%)的房性快速心律失常发生率无差异。1.9%的患者发生窦房结功能障碍,但绝大多数患者(85.7%)无症状。DDD组的手术翻修率有更高的趋势(VDD起搏器为3.3%,DDD组为6.1%,P = 0.15)。VDD起搏器患者房室同步起搏模式的累积维持率为94.9%,DDD装置患者为92.1%(无统计学差异)。
单导联VDD起搏具有植入过程更简单的优点,对于房室传导阻滞且术前窦房结功能正常的患者,其长期效果与DDD起搏相当。